800-TEMPLE-MED Schedule Appointment
SEARCH TEMPLE HEALTH

Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

view all Clinical Trials

Overview

Study RIN-PF-305 is a Phase 3, multinational, randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of inhaled treprostinil in subjects with PPF over a 52-week period.

Clinical Trial Information

Protocol

TIRB#: 32025

Phase

3

Condition(s)

Interstitial Lung Disease (ILD), Pulmonary Fibrosis (Including IPF)

Investigator

Parth Rali, MD

Coordinator

Kim Selwood

Visit clinicaltrials.gov for full description.

Contact

For more information about this trial or to inquire about eligibility, email [email protected] or call 215-707-1359.

Full Title

A Randomized, Double-blind, Placebo-controlled, Multinational, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)